(Q80376122)
Statements
A retrogen plasmid-based vaccine generates high titer antibody responses against the autologous cancer antigen survivin and demonstrates anti-tumor efficacy (English)
Dario C Altieri
William K Decker
Jianxia Qiu
Farhang Farhangfar
Jenny H Hester
Augustine Y Lin